We serve Chemical Name:1-Bromo-2-methoxy-4-methyl-5-nitrobenzene CAS:861076-28-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-Bromo-2-methoxy-4-methyl-5-nitrobenzene
CAS.NO:861076-28-0
Synonyms:4-Brom-6-nitro-3-methoxy-toluol;2-Brom-5-methyl-4-nitro-anisol;Methyl-(6-brom-4-nitro-3-methyl-phenyl)-aether;2-Bromo-5-methyl-4-nitroanisole;6-Brom-3-methyl-4-nitro-anisol;C-8740;1-bromanyl-2-methoxy-4-methyl-5-nitro-benzene
Molecular Formula:C8H8BrNO3
Molecular Weight:246.05800
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.05000
Exact Mass:244.96900
LogP:3.19750
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Brom-6-nitro-3-methoxy-toluol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-bromanyl-2-methoxy-4-methyl-5-nitro-benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Brom-3-methyl-4-nitro-anisol Use and application,1-bromanyl-2-methoxy-4-methyl-5-nitro-benzene technical grade,usp/ep/jp grade.
Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 1-Bromo-2-methoxy-4-methyl-5-nitrobenzene manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. 1-Bromo-2-methoxy-4-methyl-5-nitrobenzene supplier The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. 1-Bromo-2-methoxy-4-methyl-5-nitrobenzene vendor The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. 1-Bromo-2-methoxy-4-methyl-5-nitrobenzene factory The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.
